|
2010
|
Invention
|
Polymorphic forms of fluvastatin sodium and process for preparing the same.
Disclosed herein are... |
|
2009
|
Invention
|
Process for producing dihalopyridines. Disclosed herein an improved process for producing 2,3-dih... |
|
|
Invention
|
Extended release pharmaceutical composition of minocycline and process thereof. Disclosed herein ... |
|
|
Invention
|
Multiparticulate extended release pharmaceutical composition of carbamazepine and process for man... |
|
2008
|
Invention
|
Stabilized sustained release composition of bupropion hydrochloride and process for preparing the... |
|
|
Invention
|
Process for producing 6(r)-[2-(8'(s)-2 ',2 '-dimethylbutyryloxy-2'(s),6'(r)-dimethyl-1,2,6,7', 8'... |
|
|
Invention
|
Water dispersible pharmaceutical formulation and process for preparing the same.
Water dispersib... |
|
|
Invention
|
Water dispersible pharmaceutical formulation and process for preparing the same. Disclosed herein... |
|
2007
|
Invention
|
Modified release pharmaceutical composition of bupropion hydrochloride.
A delayed extended relea... |
|
|
Invention
|
Modified release pharmaceutical composition of bupropion hydrochloride. A delayed extended releas... |
|
|
Invention
|
Process for producing sulphoxide compounds. Disclosed herein, a process for producing sulphoxide ... |
|
|
Invention
|
Process for producing 10-oxo-l10, 11-dihydr0-5h-dibenz [b, f] azepine-5-carboxamide starting from... |
|
|
Invention
|
Process for producing 10-oxo-10, 11-dihydr0-5h-dibenz [b, f] azepine-5-carboxamide starting from ... |
|
|
Invention
|
Extended release pharmaceutical formulation of propranolol hydrochloride. Disclosed herein an ext... |
|
|
Invention
|
Process for stabilization of olanzapine polymorphic form i. Disclosed herein a process for stabil... |
|
|
Invention
|
Pharmaceutical formulations comprising oxcarbazepine and methods thereof. A solid dispersion or ... |
|
|
Invention
|
Process for the production of hetreroaromatic nitriles, improved catalyst therefor and a process ... |
|
|
Invention
|
Extended release pharmaceutical formulation comprising venlafaxine hydrochloride. Disclosed herei... |
|
|
Invention
|
Taste masked phamaceutical composition for oral solid dosage form and process for preparing the s... |
|
|
Invention
|
Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the ... |
|
|
Invention
|
Extended release pharmaceutical formulation of venlafaxine and method of manufacturing the same. ... |
|
|
Invention
|
Process for producing substituted sulphoxides. A process for preparing substituted sulphoxide usi... |
|
2006
|
Invention
|
Stable pharmaceutical formulation of an acid labile compound and process for preparing the same. ... |
|
|
Invention
|
Eco-friendly process for recovery of pyridine and/or its derivatives. A process recovers of pyrid... |
|
|
Invention
|
Eco-friendly process for recovery of pyridine and/or its derivatives. Disclosed herein is a proce... |
|
|
Invention
|
Process for preparing paroxetine hydrochloride hemihydrate. Disclosed herein a process for the pr... |
|
|
Invention
|
Stable coated pharmaceutical formulation of olanzapine and process for preparing the same. Disclo... |
|
|
Invention
|
Novel polymorphic forms of l-benzyl-4-⏧(5,6-dimethoxy-l-indanone)-2-yl]methyl piperidine ⏧do... |
|
|
Invention
|
Mouth dissolving pharmaceutical composition and process for preparing the same using a high amoun... |
|
|
Invention
|
Process for preparing a pure polymorphic form of 3-pyridyl-1-hydroxyethylidine-1, 1-bisphosphonic... |
|
|
Invention
|
Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4]... |
|
|
Invention
|
Process for producing 2-(n-butyl)-3-⏧⏧2'-(tetrazol-5-yl)biphenyl- 4-yl]methyl]-l,3... |
|
|
Invention
|
Process for producing oxcarbazepine via an 11-alkoxy-10-halo-dihydroiminostilbene intermediate. D... |
|
|
Invention
|
Novel polymorphic form of (l-benzyl-4-⏧(5,6-dimethoxy-l- indanone)-2-yl]methyl piperidine hy... |
|
|
Invention
|
Process for producing pure and stable form of 2-methyl-4-(4-methyl-1-piperazinyl) -10h-thieno[2,3... |
|
|
Invention
|
Process for producing pure and stable form of 2-methyl-4-(4- methyl- 1 -piperazinyl)-10h-thieno⏧2... |
|
|
Invention
|
Polymorphic forms of fluvastatin sodium and process for preparing the same. F3 and are characteri... |
|
|
Invention
|
Process for the preparation of amorphous atorvastatin calcium salt.
Disclosed is a novel process... |
|
|
Invention
|
Process for the preparation of amorphous atorvastatin calcium salt. Disclosed is a novel process ... |
|
2005
|
Invention
|
Process for producing biphosphonic acids and forms thereof. Disclosed herein is a process for pro... |
|
|
Invention
|
Process for producing bisphosphonic acids and forms thereof. Disclosed herein is a process for pr... |
|
2004
|
Invention
|
Process for the preparation of risperidone.
A process is provided for the preparation of risper... |
|
|
Invention
|
Process for lactonization in the preparation of statins. The present invention relates to an impr... |
|
|
Invention
|
Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2,3-b][1,5]benz... |
|
|
Invention
|
Process for producing 2-(phenyl methyl thio)-3-pyridine carboxylic acid. The invention discloses ... |
